Clinical Trials Directory

Trials / Completed

CompletedNCT01218191

Acute Neurocardiogenic Injury After Subarachnoid Hemorrhage.

Acute Neurocardiogenic Injury After Subarachnoid Hemorrhage Assessed With Cardiac 18F-FDG PET and 123I-MIBG Scintigraphy: a Prospective Observational Study.

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Direction Centrale du Service de Santé des Armées · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to describe acute neurocardiogenic injury after subarachnoid hemorrhage assessed with cardiac 123I-MIBG scintigraphy and 18F-FDG PET/CT during the first week and the first six months after SAH. The study hypothesis is that the evolution of the cardiac disturbances follows the clinical evolution.

Detailed description

The cardiac metabolic disturbance are assessed by a 18F-FDG PET/CT in the first week after SAH and monthly until normal result. The myocardial sympathetic innervation is assessed by a cardiac 123I-MIBG scintigraphy in the first week after SAH and six months later. Clinical outcome is assessed by Glasgow Outcome Scale, modified Rankin Scale and MOS-SF36 at 1, 3 and 6 months after SAH.

Conditions

Timeline

Start date
2010-02-01
Primary completion
2012-02-01
Completion
2012-02-01
First posted
2010-10-11
Last updated
2012-02-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01218191. Inclusion in this directory is not an endorsement.